We will rely on you to help lend your voice and support the biotechnology industry.
Bringing new treatments to patients, support public policies that promote innovation, improve patient access.
BIO International Convention
June 3-6, 2019
BIO World Congress on Industrial Biotechnology and Ag Tech
July 8-11, 2019
BIO Industry Analysis Reports >>
Save. Advocate. Connect. Join Us.
Search BIO members.
July 8 - 11, 2019 | Des Moines, Iowa
Hendrik Waegeman obtained a master degree in biochemical engineering at Ghent University (2007) and holds a PhD in Applied Biological Sciences-Chemical Engineering (2011), also obtained at Ghent University. During his doctoral research he metabolically engineered Esherichia coli to improve recombinant protein production. During his post-doctoral research, Hendrik Waegeman was involved in a number of projects that focused on the fermentative production of specialty carbohydrates. He is also a co-founder of the company Inbiose, founded in 2013, which develops fermentatively produced specialty carbohydrates such as human milk oligoscaccharides. In 2012 he was guest lecturer at the University of Incheon, South-Korea where he lectured a course on Metabolic Engineering and Modelling of Micro-organisms. Since 2012, he has a position at Bio Base Europe Pilot Plant, a multi-purpose pilot facility in the Port of Ghent in Belgium where he since 2015 works as Head of Business Development.
This speaker's sessions: